Skip to main content

Table 2 ITN use, care-seeking, diagnosis and treatment of fever

From: Access and adequate utilization of malaria control interventions in rural Malawi: a descriptive quantitative study

Participants

Total

Childrena (%)

Womena (%)

p value

ITN used previous night

646 (31.6)

297 (33.5)

349 (30.2)

0.104

Reported fever

N (%)

n (%)

n (%)

p value

Total with fever (% of participants)

401 (19.5)

196 (22.1)

205 (17.6)

0.013*

Sought treatment at PHC

152 (37.6)

88 (44.9)b

64 (31.2)

0.005*

Sought treatment at PHC within 24 h

78 (19.5)

43 (21.9)

35 (17.1)

0.219*

Self-treatment or private clinics

52 (13.0%)

26 (13.2)

26 (12.7)

0.862*

Mean distance to access care in km, (95% CI)

 PHC

 

3.0, (2.5–3.4)

2.7, (2.0–3.3)

0.487**

 Village clinic

 

1.9, (0.6–3.2)

NA

 

Diagnosis and treatment: n (% or SD)

 Finger prick

165 (41.1)

96 (49.0)

69 (33.7)

0.002*

 Drugs prescribed

191 (47.6)

109 (57.1)

82 (42.9)

0.191

  AL

105 (26.2)

69 (35.2)

36 (17.6)

< 0.001*

  Other anti-malarial drugc

22 (5.5)

15 (3.6)

7 (1.0)

0.10

  Antibiotics

29 (7.2)

18 (9.2)

11 (5.4)

0.401

 Paid for treatment

86 (21.4)

41 (20.9)

45 (22.0)

0.809

 Amount in MK (SD)

 

450 (186–714)

426 (297–555)

0.863

  1. AL artemether–lumefantrine, AMD anti-malarial drug, MK Malawi Kwacha, PHC primary health care facility (provide diagnosis and treatment for malaria)
  2. * χ2; ** t test. Italic p values are statistically significant
  3. aChildren aged 6–59 months and women aged 15–49 months
  4. b8 children were seen at village clinic
  5. cOther anti-malarial drugs were sulfadoxine–pyrimethamine, quinine and artesunate–amodiaquine (second line treatment of uncomplicated malaria)